HRCT SCREENING

HRCT SCREENING is a high-resolution computed tomography examination used for an initial assessment of the lungs when a referring doctor wants to look for selected pulmonary abnormalities. The examination uses thin-section CT images and high-resolution reconstruction techniques to provide more detail of lung tissue and airways than a conventional chest X-ray.

In this catalogue, HRCT Screening should be understood as a doctor-directed chest imaging service rather than a general health check for everyone. The exact protocol, scan coverage, radiation dose and number of image series can vary according to the diagnostic centre's approved screening protocol and the clinical indication written on the prescription.

The scan may help identify areas of lung infection, inflammation, ground-glass opacity, consolidation, interstitial change, fibrosis, bronchiectasis, emphysema or other abnormalities visible on CT. However, an abbreviated screening protocol may not include every additional view or reconstruction used in a comprehensive diagnostic HRCT Chest examination.

HRCT Screening is generally performed without intravenous contrast because its main purpose is to assess lung parenchyma. It is not equivalent to a contrast-enhanced CT Chest, CT pulmonary angiography, CT aortography or a formally defined low-dose lung-cancer screening examination. If a mass, blood-vessel condition, pulmonary embolism, mediastinal abnormality or complex lung disease is suspected, the doctor may recommend a different or more comprehensive CT protocol.

Benefits of the Test

• Provides thin-section images of the lungs with greater detail than a routine chest X-ray.
• May identify selected lung abnormalities at an early stage of clinical evaluation.
• Can show ground-glass opacity, consolidation and other patterns of lung involvement.
• May demonstrate interstitial changes, fibrosis, bronchiectasis or emphysema.
• Helps estimate the location and distribution of visible pulmonary abnormalities.
• Is fast, non-invasive and generally painless.
• Usually does not require intravenous contrast material.
• Can support decisions about whether a complete diagnostic HRCT or another test is required.
• Provides multiplanar images when included in the centre's protocol.
• May offer additional information when symptoms persist despite an inconclusive chest X-ray.

Why Doctors Recommend This Test

Doctors may recommend HRCT Screening when a patient has respiratory symptoms or a clinical risk that requires an initial CT assessment of the lungs. Symptoms may include persistent cough, shortness of breath, reduced oxygen saturation, fever or unexplained respiratory discomfort. The decision to perform the scan should be based on medical evaluation rather than patient self-screening.

The examination may be requested when an infection or inflammatory lung abnormality is suspected but a chest X-ray does not provide sufficient information. CT can demonstrate fine changes within the lungs and show the distribution of visible abnormalities. Imaging findings cannot identify the responsible organism by themselves, so laboratory tests and clinical correlation may still be required.

HRCT Screening may reveal features suggesting interstitial lung disease or pulmonary fibrosis. These can include ground-glass opacity, reticulation, traction bronchiectasis or honeycombing. If such findings are detected, a pulmonologist may recommend a comprehensive diagnostic HRCT protocol, pulmonary-function tests, blood tests, exposure assessment or multidisciplinary review.

The scan may help detect bronchiectasis, in which the airways become abnormally widened, or emphysema, in which lung tissue is damaged and air spaces become enlarged. The significance of these findings depends on symptoms, smoking history, exposure history and pulmonary-function results.

Doctors may also recommend the examination for selected follow-up purposes when a limited CT assessment is considered sufficient. However, repeated CT examinations should be medically justified because CT uses ionizing radiation. The timing and protocol of follow-up scans should be determined by the treating doctor.

HRCT Screening should not be described as a guaranteed method for ruling out all chest disease. Small airway abnormalities, blood clots, vascular disease, mediastinal masses and certain cancers may require other imaging protocols. A normal screening result does not exclude every cause of cough, chest pain or breathlessness.

Preparation Before Test

Most non-contrast HRCT Screening examinations require no fasting or special preparation. Patients can generally eat, drink and take regular medicines normally unless Focus Diagnostics or the referring doctor provides different instructions.

Wear loose, comfortable clothing and remove necklaces, jewellery, underwire garments and other metal objects from the chest area. Patients may be asked to change into a gown because metallic items can create artifacts that reduce image quality.

Bring the doctor's prescription and make sure the clinical indication is clearly written. Patients should also bring previous chest X-rays, CT scans, HRCT images, pulmonary-function reports, laboratory results and relevant medical records. Comparing current images with previous studies can help determine whether findings are new, stable, improving or progressing.

Inform the imaging team about current symptoms, previous lung disease, respiratory infection, chest surgery, oxygen therapy, smoking history and occupational or environmental exposure. Details about exposure to dust, fumes, asbestos, silica, mould or birds may be clinically relevant.

Women who are pregnant or may be pregnant must notify the referring doctor and CT team before the examination. The healthcare professionals can assess the medical need, radiation exposure and whether another approach is suitable. Children and younger patients require protocols adjusted according to body size and clinical necessity.

During the scan, the patient usually lies on the back with the arms positioned above the head when possible. The technologist will give breathing instructions. The patient is commonly asked to take a deep breath, hold it briefly and remain still while the images are acquired.

An abbreviated screening protocol may not routinely include expiratory or prone images. If the referring doctor requires detailed assessment of air trapping, dependent opacities or interstitial lung disease, a complete HRCT Chest protocol may be more appropriate.

Normal Reporting Time

The image acquisition usually takes only a few minutes. Registration, review of the prescription, positioning, breathing practice and image reconstruction increase the total appointment time. Patients who have difficulty holding their breath may require additional guidance or repeat acquisition if motion affects image quality.

Many routine HRCT Screening reports may be available within 24 to 48 hours. Cases with extensive abnormalities, the need to compare previous scans or findings requiring specialist review may take longer. Urgent findings are prioritized according to clinical requirements and the centre's procedures.

Scan duration and reporting time are different. Although images are captured quickly, the radiologist must examine both lungs systematically and describe the pattern, location and extent of visible abnormalities before issuing the report.

The report should be reviewed by the referring doctor. Technical terms such as ground-glass opacity, consolidation, reticulation, bronchiectasis, emphysema or fibrosis must be interpreted in the context of the patient's symptoms, clinical examination and laboratory results.

Who Should Take This Test?

HRCT Screening may be appropriate for patients whom a qualified healthcare professional has selected for an initial high-resolution assessment of lung tissue. It may be considered when respiratory symptoms, abnormal oxygen measurements, exposure history or an inconclusive chest X-ray require further evaluation.

The examination may be useful for selected patients with suspected infection, inflammation, interstitial change, bronchiectasis, emphysema or occupational lung disease. It can also help determine whether a comprehensive diagnostic HRCT, contrast-enhanced CT or another investigation is necessary.

HRCT Screening is not intended as a routine annual scan for healthy individuals without a defined indication. It should also not be confused with low-dose lung-cancer screening, which is intended for specifically eligible high-risk individuals and uses a formally defined protocol.

Patients with severe respiratory symptoms require clinical assessment in addition to imaging. Sudden or severe breathlessness, bluish discoloration, chest pain, confusion, coughing up significant blood or rapidly falling oxygen levels may represent an emergency and require immediate medical attention.

Pregnant patients, children and people who have undergone multiple previous CT scans need individualized consideration. The expected diagnostic benefit should justify radiation exposure, and previous images should be reviewed to avoid unnecessary repeat examinations.

Detailed Information

The lungs contain branching airways and millions of small air sacs supported by a delicate interstitial framework. Many lung conditions change the appearance of these structures. Thin-section CT images can show abnormalities that are too subtle or too widely distributed to be characterized fully on a chest X-ray.

HRCT uses thin image acquisition or reconstruction and a high-spatial-frequency algorithm to emphasize fine lung detail. The radiologist reviews the images using lung-specific display settings and may also inspect mediastinal windows for additional information. The exact technique depends on the equipment and approved centre protocol.

Ground-glass opacity is an area of increased lung density through which underlying vessels remain visible. It is a non-specific finding that can occur with infection, inflammation, fluid, partial filling of air spaces or early interstitial disease. It does not identify one particular illness by itself.

Consolidation is denser lung opacity that obscures underlying vessels. It may occur with infection, inflammation, bleeding or other conditions. Clinical symptoms and laboratory investigations are required to determine the likely cause.

Reticulation refers to a network of fine lines within the lungs. Traction bronchiectasis occurs when fibrotic tissue pulls airways open, while honeycombing describes clustered cystic spaces that may indicate established fibrosis in an appropriate clinical context.

Bronchiectasis is assessed by examining airway diameter, wall thickness, tapering and visibility toward the outer lungs. Mucus plugging or small nodules may be associated findings. Pulmonary-function testing and microbiological investigation may be required depending on symptoms.

Emphysema appears as areas of abnormally low lung density resulting from destruction and enlargement of air spaces. The pattern and distribution can be described on CT, but spirometry and clinical assessment are needed to evaluate functional impact.

A screening protocol may detect an unexpected lung nodule or other incidental finding. Management depends on features such as size, appearance, patient age, smoking history and previous imaging. Not every nodule is cancerous, and the radiologist may recommend follow-up according to the clinical situation.

HRCT Screening does not normally use contrast and therefore is not optimized for pulmonary arteries or detailed assessment of vascular enhancement. If pulmonary embolism is suspected, CT pulmonary angiography is usually required. If a mediastinal mass or lymph-node abnormality needs characterization, CECT Chest may be recommended.

CT uses ionizing radiation. The dose depends on patient size, scan coverage and the centre's protocol. Additional scan phases increase radiation exposure, so only clinically necessary acquisitions should be performed. The imaging team selects parameters intended to maintain diagnostic quality while limiting unnecessary exposure.

After a routine non-contrast HRCT Screening examination, patients can generally resume normal activities immediately. The scan itself does not provide treatment. The final report should be reviewed by the referring doctor or pulmonologist, who will decide whether medication, pulmonary-function testing, laboratory investigation, follow-up imaging or a complete diagnostic examination is necessary.